Login / Signup
Therapeutic potential of the interleukin-4/interleukin-13 inhibitor dupilumab for treating IgG4-related disease.
Isana Nakajima
Yoshinori Taniguchi
Hideki Tsuji
Tomoka Mizobuchi
Ken Fukuda
Published in:
Rheumatology (Oxford, England) (2022)
Keyphrases
</>
atopic dermatitis